Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2012
Double down for a double win
Pearl S Huang
FASEB Bioadvances
|
November 11, 2021
The nervous system: Orchestra conductor in cancer, regeneration, inflammation and immunity
Hubert Hondermarck, Pearl S Huang, John A Wagner
Chinese Journal of Cancer
|
June 2, 2011
A proposal: a comprehensive platform to characterize tumors in Chinese and improve success in cancer drug discovery and development
Pearl S Huang, Peter T Ho, Kang Zhang
Analytical Biochemistry
|
February 5, 2005
A method for determining intracellular concentrations of enzyme substrates from a combination of competitive inhibition and mutagenesis studies
Robert A Copeland, Lusong Luo, Kurt R Auger, et al.
Nature Reviews. Cancer
|
January 26, 2007
Targeted anti-mitotic therapies: can we improve on tubulin agents?
Jeffrey R Jackson, Denis R Patrick, Mohammed M Dar, et al.
Biochemistry
|
December 1, 2004
Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition
Lusong Luo, Jeffrey D Carson, Dashyant Dhanak, et al.
BMC Medical Genomics
|
January 22, 2011
EMT is the dominant program in human colon cancer
Andre Loboda, Michael V Nebozhyn, James W Watters, et al.
Journal of the American Chemical Society
|
May 22, 2008
Conformation-dependent ligand regulation of ATP hydrolysis by human KSP: activation of basal hydrolysis and inhibition of microtubule-stimulated hydrolysis by a single, small molecule modulator
Lusong Luo, Jeffrey D Carson, Kathleen S Molnar, et al.
Nature Chemical Biology
|
October 9, 2007
ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism
Lusong Luo, Cynthia A Parrish, Neysa Nevins, et al.
Cancer Research
|
April 3, 2008
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity
Nelson Rhodes, Dirk A Heerding, Derek R Duckett, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2012
Double down for a double win
Pearl S Huang
FASEB Bioadvances
|
November 11, 2021
The nervous system: Orchestra conductor in cancer, regeneration, inflammation and immunity
Hubert Hondermarck, Pearl S Huang, John A Wagner
Chinese Journal of Cancer
|
June 2, 2011
A proposal: a comprehensive platform to characterize tumors in Chinese and improve success in cancer drug discovery and development
Pearl S Huang, Peter T Ho, Kang Zhang
Analytical Biochemistry
|
February 5, 2005
A method for determining intracellular concentrations of enzyme substrates from a combination of competitive inhibition and mutagenesis studies
Robert A Copeland, Lusong Luo, Kurt R Auger, et al.
Nature Reviews. Cancer
|
January 26, 2007
Targeted anti-mitotic therapies: can we improve on tubulin agents?
Jeffrey R Jackson, Denis R Patrick, Mohammed M Dar, et al.
Biochemistry
|
December 1, 2004
Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition
Lusong Luo, Jeffrey D Carson, Dashyant Dhanak, et al.
BMC Medical Genomics
|
January 22, 2011
EMT is the dominant program in human colon cancer
Andre Loboda, Michael V Nebozhyn, James W Watters, et al.
Journal of the American Chemical Society
|
May 22, 2008
Conformation-dependent ligand regulation of ATP hydrolysis by human KSP: activation of basal hydrolysis and inhibition of microtubule-stimulated hydrolysis by a single, small molecule modulator
Lusong Luo, Jeffrey D Carson, Kathleen S Molnar, et al.
Nature Chemical Biology
|
October 9, 2007
ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism
Lusong Luo, Cynthia A Parrish, Neysa Nevins, et al.
Cancer Research
|
April 3, 2008
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity
Nelson Rhodes, Dirk A Heerding, Derek R Duckett, et al.
Page
of 2